ETHAN - ET for Male BC
Conditions: Male Breast Cancer; Hormone Receptor-positive Breast Cancer; Hormone Receptor Negative Breast Carcinoma Interventions: Drug: Tamoxifen; Drug: Anastrozole; Drug: Degarelix; Drug: Abemaciclib Sponsors: Jose Pablo Leone; Eli Lilly and Company; Translational Breast Cancer Research Consortium (TBCRC) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Arimidex | Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Research | Tamoxifen